Skip to main content
. 2021 Apr 18;29(6):850–865. doi: 10.5551/jat.62821

Fig.3. Kaplan–Meier estimates of the 5-year incidences of endpoint events after randomization into the probucol group with an average decrease in HDL cholesterol from baseline of 6.25 mg/dL or more and ＜6.25 mg/dL.

Fig.3. Kaplan–Meier estimates of the 5-year incidences of endpoint events after randomization into the probucol group with an average decrease in HDL cholesterol from baseline of 6.25 mg/dL or more and ＜6.25 mg/dL

The adjusted HR was calculated using a stratified proportional hazards model (with baseline LDL-C, the presence or absence of diabetes, and the presence or absence of hypertension as covariates and the study as a stratified factor).